Pharvaris N.V.
PHVS
$14.00
$0.282.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 50.33% | 40.24% | 24.77% | 14.36% | 10.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.23% | 39.17% | 33.99% | 22.76% | 14.98% |
| Operating Income | -50.23% | -39.17% | -33.99% | -22.76% | -14.98% |
| Income Before Tax | -32.85% | -25.51% | -23.68% | -33.21% | -36.28% |
| Income Tax Expenses | 73.14% | 126.79% | 169.40% | 57.80% | 33.05% |
| Earnings from Continuing Operations | -33.27% | -26.08% | -27.56% | -33.46% | -36.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.27% | -26.08% | -27.56% | -33.46% | -36.25% |
| EBIT | -50.23% | -39.17% | -33.99% | -22.76% | -14.98% |
| EBITDA | -50.45% | -39.40% | -34.11% | -22.78% | -14.90% |
| EPS Basic | 5.06% | 12.87% | 9.14% | -4.93% | -19.01% |
| Normalized Basic EPS | 5.45% | 13.33% | 11.95% | -4.81% | -19.18% |
| EPS Diluted | 5.06% | 12.87% | 9.14% | -4.93% | -19.01% |
| Normalized Diluted EPS | 5.45% | 13.33% | 11.95% | -4.81% | -19.18% |
| Average Basic Shares Outstanding | 40.78% | 43.92% | 41.78% | 28.45% | 14.26% |
| Average Diluted Shares Outstanding | 40.78% | 43.92% | 41.78% | 28.45% | 14.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |